Global healthcare M&A rebounded strongly in 2025, with deal value up 38% as buyers shifted toward fewer, larger and more strategic acquisitions. In the mid-market, heightened selectivity is favouring assets with proven cash flows, strong market positions and embedded AI capabilities. Looking ahead, improving exit conditions and demand driven by aging populations, digital productivity and value-based care are creating a cautiously optimistic outlook for 2026.

Global dealmakers 2026: Mid-market healthcare M&A data pulse, published in partnership with Baker Tilly International, provides valuable insights into global TMT M&A trends and opportunities.

Access to learn about:

• Sector deal value and volumes trends and how this benchmarks against global M&A performance
• Key markets and cross-border M&A hotspots
• Subsectors driving the most activity